Trials / Completed
CompletedNCT05931237
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
Evaluation of the Inter-individual Variability Associated With the Interaction Between Flavan-3-ols From Cranberry and Gut Microbiota - an Exploratory Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Consumption of (poly)phenols is recognized to have beneficial effects on health. However, heterogeneous results are obtained in clinical trials due to high inter-individual variability. The objective of this pilot study is to characterize the inter-individual variability associated with the interaction of (poly)phenols from cranberry and gut microbiota. The participants (n=39) of this study are healthy adults aged between 23 and 63 years old and consumed cranberry extract rich in (poly)phenols for 4 days. Plasma, urine and feces were collected to quantify gut microbial (poly)phenols metabolites and to profile the fecal microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cranberry extract capsules | Cranberry extract capsules (Prebiocran(TM)) |
Timeline
- Start date
- 2021-09-09
- Primary completion
- 2021-11-19
- Completion
- 2021-11-19
- First posted
- 2023-07-05
- Last updated
- 2023-07-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05931237. Inclusion in this directory is not an endorsement.